Blog
Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Form 8.3 - The Vanguard Group, Inc.: International Distribution Services plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Hargreaves Lansdown plc
Form 8.3 - The Vanguard Group, Inc.: Britvic plc
Form 8.3 - The Vanguard Group, Inc.: Britvic plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc
Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc
Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK plc
EQS-News: Shelly further optimizes management structures for greater punch in growth and internationalization
EQS-News: Shelly further optimizes management structures for greater punch in growth and internationalization
Edison issues report on The Biotech Growth Trust (BIOG)
Edison issues report on The Biotech Growth Trust (BIOG)
Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula
Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula
Hardman & Co Research on H&T Group: 1H’24 results - Four-one at half time, but the one wins
Hardman & Co Research on H&T Group: 1H’24 results - Four-one at half time, but the one wins
Director/PDMR Shareholding
Director/PDMR Shareholding
EQS-News: Mynaric Announces Voluntary Departure of CFO Stefan Berndt von-Bülow
EQS-News: Mynaric Announces Voluntary Departure of CFO Stefan Berndt von-Bülow
EQS-Adhoc: Mynaric Lowers Revenue, Cash-In from Customer Contracts and Increases Operating Loss Guidance for 2024 Due to Slower than Expected Production Ramp and Higher Production Costs
EQS-Adhoc: Mynaric Lowers Revenue, Cash-In from Customer Contracts and Increases Operating Loss Guidance for 2024 Due to Slower than Expected Production Ramp and Higher Production Costs
EQS-News: Veganz Mililk® now available in organic food shops
EQS-News: Veganz Mililk® now available in organic food shops
EQS-News: Photon Energy Group Reports Financial and Operational Results for the First Half of 2024
EQS-News: Photon Energy Group Reports Financial and Operational Results for the First Half of 2024
EQS-News: IMMOFINANZ sells office development in Bucharest
EQS-News: IMMOFINANZ sells office development in Bucharest
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: audius SE converts from bearer shares to registered shares
EQS-News: audius SE converts from bearer shares to registered shares
EQS-News: Nordex Group receives orders from Akfen Renewable Energy for 102 MW in Türkiye
EQS-News: Nordex Group receives orders from Akfen Renewable Energy for 102 MW in Türkiye
EQS-News: PANTAFLIX Subsidiary STORYBOOK STUDIOS Produces First AI-Generated Animated Series with SPACE VETS
EQS-News: PANTAFLIX Subsidiary STORYBOOK STUDIOS Produces First AI-Generated Animated Series with SPACE VETS
EQS-News: SFC Energy delivers strong half-year financials – further improved net cash position of around EUR 66 million – international expansion and capacity build up according to plan
EQS-News: SFC Energy delivers strong half-year financials – further improved net cash position of around EUR 66 million – international expansion and capacity build up according to plan
EQS-News: Flughafen Wien AG in the first half of 2024: Increase in passenger volume, revenue and earnings
EQS-News: Flughafen Wien AG in the first half of 2024: Increase in passenger volume, revenue and earnings
DocMorris grows in the prescription business and invests incrementally in new Rx customers
DocMorris grows in the prescription business and invests incrementally in new Rx customers
HUBER+SUHNER reports clear upward trend compared to second half of 2023
HUBER+SUHNER reports clear upward trend compared to second half of 2023


